The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

42 articles for J Lai


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.EBI
University of Arizona
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.EBI
University of Arizona
Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.EBI
University of Arizona
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.EBI
University of Arizona
Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.EBI
Vrije Universiteit Brussel
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.EBI
University of Arizona
Biological active analogues of the opioid peptide biphalin: mixeda/ß(3)-peptides.EBI
D'Annunzio University of Chieti���Pescara
Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation.EBI
3-V Biosciences
cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2.EBI
D'Annunzio University of Chieti���Pescara
The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.EBI
D'Annunzio University of Chieti���Pescara
Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.EBI
University of Arizona
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.EBI
University of Arizona
Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.EBI
University of Arizona
Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkers.EBI
University of Arizona
Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.EBI
University of Arizona
Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.EBI
Vrije Universiteit Brussel
Discovery of a potent and efficacious peptide derivative ford/µ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.EBI
University of Arizona
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.EBI
Sapienza University of Rome
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.EBI
University of Arizona
Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.EBI
Sapienza University of Rome
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.EBI
University of Arizona
Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.EBI
University of Arizona
Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.EBI
Sapienza University of Rome
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.EBI
University of Arizona
Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.EBI
University of Arizona
Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors.EBI
University of Arizona
Synthesis and biological activity of the first cyclic biphalin analogues.EBI
University of Arizona
Mapping the kinase domain of Janus Kinase 3.EBI
Aventis Pharmaceuticals
Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.EBI
University of Arizona
Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.EBI
University of Arizona
Chiral Effect of a Phe Residue in Position 3 of the DmtEBI
University of Arizona
Effect of anchoring 4-anilidopiperidines to opioid peptides.EBI
University of Arizona
Combination therapy with glutaminase inhibitorsBDB
Calithera Biosciences
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsBDB
Incyte
ImmunomodulatorsBDB
Bristol-Myers Squibb
Pyrrolobenzodiazepines and conjugates thereofBDB
Mersana Therapeutics
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Triazolopyridines and triazolopyrazines as LSD1 inhibitorsBDB
Incyte
Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.BDB
Smithkline Beecham Pharmaceuticals
Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.BDB
Universita Degli Studi Di Firenze
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.BDB
University of Nottingham
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).BDB
Smithkline Beecham Pharmaceuticals